Featured Clinical Trials

Hollings Cancer Center strives to bring its patients cutting edge cancer treatment options. Below is a listing of featured trials available at Hollings Cancer Center.

A Phase II Study of ABC294640 in Patients with Advanced Hepatocellular Carcinoma Who Have Progressed on Sorafenib
PI: Carolyn Britten
Study Coordinator: Lindsay Winter winterl@musc.edu
A Phase II Trial of Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse after Radical Prostatectomy
PI: Michael Lilly
Study Coordinator: Mike Wheeler wheelerm@musc.edu
A Phase IB/II Study Of Nivolumab In Combination With ALT-803 In Patients With Pretreated, Advanced Or Metastatic Non-Small Cell Lung Cancer
PI: John Wrangle
Study Coordinator: Eleanor Hardy hardyel@musc.edu